Aarti Pharmalabs Ltd Nine Monthly Results

Gross Sales

1,346.85

1,460.17

739.64

Excise Duty

0

0

0

Net Sales

1,346.85

1,460.17

739.64

Other Operating Income

0

0

0

Other Income

2.85

1.57

-0.01

Total Income

1,349.7

1,461.74

739.63

Total Expenditure

1,078.32

1,198.11

608.31

PBIDT

271.38

263.64

131.32

Interest

12.54

15.11

7.37

PBDT

258.84

248.52

123.95

Depreciation

54.11

46.59

28.05

Minority Interest Before NP

0

0

0

Tax

41.9

44.88

19.43

Deferred Tax

11.18

6.43

3.09

Reported Profit After Tax

151.65

150.62

73.38

Minority Interest After NP

0

0

0

Net Profit after Minority Interest

151.65

150.62

73.38

Extra-ordinary Items

0

0

0

Adjusted Profit After Extra-ordinary item

151.65

150.62

73.38

EPS (Unit Curr.)

16.73

16.62

16.11

Book Value (Unit Curr.)

0

0

0

Dividend (%)

40

0

0

Equity

45.31

45.31

45.56

Public Shareholding (Number)

0

0

0

Public Shareholding (%)

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

Non Encumbered - No. of Shares

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

Non Encumbered - % in Total Equity

0

0

0

PBIDTM(%)

20.14

18.05

17.75

PBDTM(%)

19.21

17.01

16.75

PATM(%)

11.25

10.31

9.92